We are live on ! Find out more
NFC

Northeast Financial Consultants Portfolio holdings

AUM $2.45B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
-4.81%
1 Year Est. Return
+15.14%
3 Year Est. Return
+63.77%
5 Year Est. Return
+108.46%
10 Year Est. Return
+198.58%
AUM
$1.73B
AUM Growth
+$69.7M
Cap. Flow
+$170M
Cap. Flow %
9.82%
Top 10 Hldgs %
46.86%
Holding
410
New
54
Increased
155
Reduced
38
Closed
22

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$23.8M
2
PFE icon
Pfizer
PFE
+$19.9M
3
VTV icon
Vanguard Morningstar Value ETF
VTV
+$13.7M
4
AMZN icon
Amazon
AMZN
+$8.29M
5
QUAL icon
iShares MSCI USA Quality Factor ETF
QUAL
+$5.51M

Top Sells

Rank Stock Value
1
BRMK
Broadmark Realty Capital Inc. Common Stock
BRMK
+$3.76M
2
XOM icon
ExxonMobil
XOM
+$3.15M
3
PSXP
PHILLIPS 66 PARTNERS LP
PSXP
+$2.69M
4
HTPA
Highland Transcend Partners I Corp.
HTPA
+$1.82M
5
VYM icon
Vanguard High Dividend Yield ETF
VYM
+$1.01M

Sector Composition

Rank Sector Weight
1 Healthcare 10.36%
2 Financials 9.62%
3 Technology 8.84%
4 Communication Services 5.22%
5 Consumer Discretionary 4.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MYN icon
376
BlackRock MuniYield New York Quality Fund
MYN
$376M
$121K 0.01%
10,000
– –
KG
377
Kestrel Group
KG
$66.3M
$119K 0.01%
2,476
– –
CMRX
378
DELISTED
Chimerix, Inc.
CMRX
$107K 0.01%
23,278
-2,524
-10% -$14.1K
KNSA icon
379
Kiniksa Pharmaceuticals
KNSA
$6.1B
$101K 0.01%
10,130
-1,310
-11% -$13.9K
KRRO icon
380
Korro Bio
KRRO
$197M
$97K 0.01%
917
+600
+189% +$115K
MGNX icon
381
MacroGenics
MGNX
$256M
$88K 0.01%
10,000
– –
AUTL
382
Autolus Therapeutics
AUTL
$564M
$82K ﹤0.01%
19,672
-2,543
-11% -$10.7K
OCUL icon
383
Ocular Therapeutix
OCUL
$2.25B
$62K ﹤0.01%
12,483
-1,532
-11% -$8.49K
ETWO.WS
384
DELISTED
E2open Parent Holdings, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50
ETWO.WS
$52K ﹤0.01%
25,500
+1,000
+4% +$2.07K
PHAS
385
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$50K ﹤0.01%
37,760
– –
LMACW
386
DELISTED
Liberty Media Acquisition Corporation Warrants
LMACW
$43K ﹤0.01%
64,170
+8,897
+16% +$9.38K
SPPI
387
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$13K ﹤0.01%
10,000
– –
RONI.WS
388
DELISTED
Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
RONI.WS
$7K ﹤0.01%
11,023
+23
+0.2% +$22
AGEN
389
Agenus
AGEN
$311M
– –
-1,410
Closed -$89K
CARR icon
390
Carrier Global
CARR
$52B
– –
-3,901
Closed -$212K
CL icon
391
Colgate-Palmolive
CL
$73.6B
– –
-2,476
Closed -$211K
CLX icon
392
Clorox
CLX
$12.8B
– –
-1,312
Closed -$229K
CRNC icon
393
Cerence
CRNC
$391M
– –
-4,271
Closed -$327K
EXPD icon
394
Expeditors International
EXPD
$24B
– –
-1,800
Closed -$242K
FTI icon
395
TechnipFMC
FTI
$29.5B
– –
-26,600
Closed -$157K
IPAY icon
396
Amplify Mobile Payments ETF
IPAY
$181M
– –
-5,043
Closed -$293K
LRMR icon
397
Larimar Therapeutics
LRMR
$454M
– –
-10,105
Closed -$109K
MRNA icon
398
Moderna
MRNA
$25.4B
– –
-1,000
Closed -$254K
NAD icon
399
Nuveen Quality Municipal Income Fund
NAD
$2.75B
– –
-10,959
Closed -$177K
OKTA icon
400
Okta
OKTA
$25.6B
– –
-900
Closed -$202K
13 14 15
16
17

Similar funds

MC
Martin Currie Edinburgh, United Kingdom $2.61B AUM 29.41% 1-Year Est. Return
WBA
Walgreens Boots Alliance Deerfield, Illinois $2.24B AUM 36.34% 1-Year Est. Return
MD
Money Design Tokyo, Japan $2.14B AUM 10.33% 1-Year Est. Return
GL
Graypoint LLC Albany, New York $1.78B AUM 16.72% 1-Year Est. Return
SVCF
Silicon Valley Community Foundation Mountain View, California $1.77B AUM 13% 1-Year Est. Return
GLA
Good Life Advisors Reading, Pennsylvania $1.6B AUM 15.83% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
MME
Meag Munich Ergo Munich, Germany $3.54B AUM 20% 1-Year Est. Return

Northeast Financial Consultants's Q1 2022 Portfolio in Review

As of Q1 2022, Northeast Financial Consultants held 410 positions worth $1.73B, up 4.2% from $1.66B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Northeast Financial Consultants deployed $170M of net new capital in Q1 2022, opening 54 new positions and adding to 155 existing holdings. Its largest new stake was Blackstone Secured Lending: 153,173 shares worth $4.27M.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 10% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Broadmark Realty Capital Inc. Common Stock, an estimated $3.76M trimmed.

  • Northeast Financial Consultants's largest Q1 2022 buy was Blackstone Secured Lending: 153,173 shares worth $4.27M.
  • Northeast Financial Consultants added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $23.8M increase.
  • Northeast Financial Consultants's biggest Q1 2022 reduction was Broadmark Realty Capital Inc. Common Stock, cutting an estimated $3.76M.
  • Northeast Financial Consultants fully exited PHILLIPS 66 PARTNERS LP in Q1 2022, selling an estimated $2.69M.
  • Northeast Financial Consultants's ten largest holdings make up 47% of its $1.73B portfolio in Q1 2022.
  • Northeast Financial Consultants opened 54 new positions and closed 22 in Q1 2022.
  • Northeast Financial Consultants's portfolio value rose 4.2% quarter-over-quarter to $1.73B.

Based on Northeast Financial Consultants's 13F filing for Q1 2022, filed 12 May 2022.